Martin Samuel Bates

Date	Company	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
14 Jun 24	CLDX Celldex Therapeutics	Common Stock	Sell	Dispose S	No	No	35.4248	17,172	608.31 k	28,125
14 Jun 24	CLDX Celldex Therapeutics	Common Stock	Option exercise	Acquire M	No	No	10.38	16,968	176.13 k	45,297
14 Jun 24	CLDX Celldex Therapeutics	Common Stock	Option exercise	Acquire M	No	No	9.0165	3,201	28.86 k	28,329
14 Jun 24	CLDX Celldex Therapeutics	Incentive Stock Option Common Stock	Option exercise	Dispose M	No	No	10.38	16,968	176.13 k	63,632
14 Jun 24	CLDX Celldex Therapeutics	Incentive Stock Option Common Stock	Option exercise	Dispose M	No	No	9.0165	3,201	28.86 k	0
13 Jun 24	CLDX Celldex Therapeutics	Incentive Stock Option Common Stock	Grant	Acquire A	No	No	36.43	81,000	2.95 mm	81,000
30 May 24	CLDX Celldex Therapeutics	Common Stock	Sell	Dispose S	No	No	34.0507	35,000	1.19 mm	25,128
30 May 24	CLDX Celldex Therapeutics	Common Stock	Option exercise	Acquire M	No	No	10.38	25,000	259.50 k	60,128
30 May 24	CLDX Celldex Therapeutics	Incentive Stock Option Common Stock	Option exercise	Dispose M	No	No	10.38	25,000	259.50 k	80,600
2 Jan 24	CLDX Celldex Therapeutics	Common Stock	Option exercise	Acquire M	No	No	2.78	10,750	29.89 k	35,128

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.